FierceBiotech2d
GSK, Merck and Pfizer in Ab&B's sights as Chinese vaccine biotech files for IPO
Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...
pharmaphorum4d
Record Shingrix sales help GSK raise 2022 forecasts
On the downside, GSK's COVID-19 therapy Xevudy (sotrovimab) saw a slump in demand, with sales falling to £500 million from £1.3 billion in the first quarter of 2022, and GSK is expecting the ...
GSK application for new Shingrix formulation accepted by FDA
GSK announced on Friday that the US Food and Drug Administration (FDA) has accepted its regulatory application for a prefilled syringe version of Shingrix, its recombinant zoster vaccine for ...
GSK’s Shingrix new prefilled syringe presentation accepted for review by FDA
GSK (GSK) announced that the US Food and Drug Administration, FDA, has accepted for review the regulatory application of a prefilled syringe ...
Monthly Prescribing Reference8d
Prefilled Syringe Presentation of Shingrix Under FDA Review
The new prefilled syringe has the same composition but removes the need for reconstitution, providing a more convenient option for health care providers who administer vaccines. According to the ...
London South East15d
Shingrix fully liquid accepted for US FDA review
GSK) today announced that the US Food and Drug Administration (FDA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK's Recombinant Zoster ...
Nairametrics12d
GSK enters agreement to acquire IDRx for $1.15 Billion to strengthen cancer portfolio
UK pharmaceutical giant GSK has confirmed that it has signed an agreement to acquire the privately-held biotechnology company ...
Nasdaq15d
GSK's Shingrix New Prefilled Syringe Presentation Accepted For Review By FDA
GSK.L) announced Friday that the US Food and Drug Administration has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix, the Recombinant Zoster Vaccine ...
London South East15d
GSK application for new Shingrix formulation accepted by FDA
(Sharecast News) - GSK announced on Friday that the US Food and Drug Administration (FDA) has accepted its regulatory application for a prefilled syringe version of Shingrix, its recombinant ...
The Pharma Letter15d
BRIEF—Prefilled syringe presentation of Shingrix accepted for review by FDA
The US Food and Drug Administration (FDA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix, GSK’s recombinant zoster vaccine for the prevention of ...
Pharmabiz14d
US FDA accepts for review GSK’s Shingrix new prefilled syringe presentation
GSK plc, a global biopharma company, announced that the US Food and Drug Administration (FDA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s ...